ATR-005

N/A

Report date: 2025/01/26 19:29:49
NME

Base Information

Drug NameATR-005
Drug Alias NameMEK pathway inhibitor (Atriva Therapeutics)ATR-005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase inhibitors
TargetsDual specificity mitogen-activated protein kinase kinase
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAtriva Therapeutics Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesAtriva Therapeutics Gmbh
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A